Avoro Capital Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Avoro Capital Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,000,000	Closed	-$810M	–	51
2023 Q3	$810M	Hold	7,000,000	–	–	12.63%	1
2023 Q2	$720M	Hold	7,000,000	–	–	9.77%	2
2023 Q1	$764M	Hold	7,000,000	–	–	11.33%	1
2022 Q4	$797M	Buy	7,000,000 +1,875,000	+37%	+$156M	11.9%	2
2022 Q3	$317M	Buy	5,125,000 +125,000	+3%	+$8.73M	5.86%	6
2022 Q2	$399M	Sell	5,000,000 -1,500,000	-23%	-$142M	7.88%	4
2022 Q1	$684M	Sell	6,500,000 -2,795,000	-30%	-$272M	12.48%	1
2021 Q4	$1B	Buy	9,295,000 +295,000	+3%	+$32.2M	17.05%	1
2021 Q3	$986M	Hold	9,000,000	–	–	15.49%	1
2021 Q2	$843M	Hold	9,000,000	–	–	14.66%	1
2021 Q1	$828M	Hold	9,000,000	–	–	14.31%	1
2020 Q4	$658M	Buy	9,000,000 +1,350,000	+18%	+$100M	11.34%	2
2020 Q3	$594M	Buy	7,650,000 +1,650,000	+28%	+$114M	8.44%	3
2020 Q2	$333M	Buy	6,000,000 +1,425,000	+31%	+$61M	6.59%	3
2020 Q1	$136M	Buy	4,575,000 +575,000	+14%	+$19.5M	4.57%	7
2019 Q4	$145M	Hold	4,000,000	–	–	4.25%	9
2019 Q3	$109M	Hold	4,000,000	–	–	4.54%	8
2019 Q2	$96.2M	Hold	4,000,000	–	–	3.33%	11
2019 Q1	$106M	Sell	4,000,000 -350,000	-8%	-$8.29M	4.57%	7
2018 Q4	$85M	Sell	4,350,000 -110,426	-2%	-$2.16M	5.08%	8
2018 Q3	$87.3M	Sell	4,460,426 -1,133,257	-20%	-$21.5M	4.01%	10
2018 Q2	$92.6M	Buy	5,593,683 +435,000	+8%	+$6.63M	3.57%	9
2018 Q1	$73.3M	Buy	5,158,683 +722,500	+16%	+$10.7M	3.5%	10
2017 Q4	$64.8M	Buy	4,436,183 +920,083	+26%	+$12.9M	4.2%	10
2017 Q3	$44.6M	Buy	+3,516,100	New	+$44.7M	3.46%	10

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Avoro Capital Advisors's HZNP Position: Q4 2023 in Review

Avoro Capital Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 7,000,000 shares — an estimated $810M sold.

Avoro Capital Advisors first reported a position in HZNP in Q3 2017 and held it in 25 quarters. The position peaked at $1B in Q4 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Avoro Capital Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Avoro Capital Advisors sold 7,000,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $810M.
Avoro Capital Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2017 and held it in 25 quarters.
Avoro Capital Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1B in Q4 2021.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Avoro Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.